Abstract: Maternal serum screening for neural tube defects and fetal aneuploidy in the second trimester has been incorporated into obstetrical practice over the past two decades. Now, as a result ...

Second-trimester screening of a pregnant woman's serum for markers of such congenital abnormalities as fetal trisomy 21 (Down syndrome) and neural tube defects has become an important part of ...

Maternal serum screening for neural tube defects and fetal aneuploidy in the second trimester has been incorporated into obstetrical practice over the past two decades. Now, as a result of several ...

Exposure to tetracycline antibiotics during the first trimester of pregnancy is not tied to increased risks of major ...

Kalter H, Warkany J: Congenital malformations ... Berry RJ, Li Zhu, Erickson JD, Li Song, Moore CA et al.: Prevention of neural tube defects with folic acid in China. N Engl J Med 1999; 341: ...

abdominal wall malformations, neural tube defects, congenital tumors, neck masses, congenital cardiac abnormalities and tongue and mouth tumors. Fellows completing this program gain enhanced ...

Kalter H, Warkany J: Congenital malformations ... Berry RJ, Li Zhu, Erickson JD, Li Song, Moore CA et al.: Prevention of neural tube defects with folic acid in China. N Engl J Med 1999; 341: ...

Today, maternal serum can be screened for a variety of fetal chromosomal and congenital malformations. Amniocentesis is an invasive procedure with an approximate 0.3%-0.5% risk of fetal loss even ...